Clinical Guidance/Position Statements/Patient Information Leaflets

Emergency Endocrine Guidance

February 2013

Apoplexy
Society for Endocrinology Emergency Endocrine Guidance - Pituitary apoplexy

This document aims to provide guidance during the initial phase of assessment and management of pituitary apoplexy.

February 2013

Hypercalcaemia
Society for Endocrinology Emergency Endocrine Guidance - Acute hypercalcaemia

This document aims to provide guidance during the initial phase of assessment and management of acute hypercalcaemia.

February 2013

Hypocalcaemia
Society for Endocrinology Emergency Endocrine Guidance - Acute hypocalcaemia (for use in adult patients)

This document aims to provide guidance during the initial phase of assessment and management of acute hypocalcaemia (in adult patients).

Clinical Guidance

December 2010

Androgens (female)
UK Guidelines Androgens Female

These guidelines on the role of androgens in the management of sexual problems in women were produced by the British Society for Sexual Medicine in association with the Society for Endocrinology and others

December 2010

Androgens (male)
UK Guidelines Androgens Male

These guidelines on the role of androgens in the management of sexual problems in men were produced by the British Society for Sexual Medicine in association with the Society for Endocrinology and others

January 2011
(reviewed no changes March 2014)

Apoplexy
Society for Endocrinology UK Guidelines for the Management of Pituitary Apoplexy

These Guidelines for the Management of Pituitary Apoplexy were produced by the Society for Endocrinology, published in Clinical Endocrinology and endorsed by the Royal College of Physicians and The Pituitary Foundation.

August 2015

Disorder of Sex Development
Society for Endocrinology revised UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development

These Guidelines on a suspected disorder of sex development were produced by the Society for Endocrinology in July 2011, reviewed in 2015 and published in Clinical Endocrinology. The revised guidelines are endorsed by the British Society for Paediatric Endocrinology & Diabetes, the Androgen Insensitivity Syndrome Support Group, the Association for Clinical Biochemistry, the British Society for Paediatric & Adolescent Gynaecology, the British Society of Paediatric Radiology, the CAH Support Group, CLIMB - the National Information Centre for Metabolic Diseases and the Royal College of Nursing, British Association of Paediatric Urologists, British Society for Genetic Medicine and Clinical Genetics Society

Society position statements/guidance

October 2010

Catecholamine-secreting phaeochromocytoma and paraganglioma
Protocol using oral phenoxybenzamine to prepare patients with catecholamine-secreting phaeochromocytoma and paraganglioma for surgery (PDF) (kb)

Suggestion of an alternative whilst supplies of the intravenous compound are being restored (reviewed March 2012).

November 2011

Dopamine Agonists
Society for Endocrinology position statement on the use of dopamine agonists in endocrine disorders

This statement (originally issued in February 2009 and reviewed November 2011) was issued in response to information contained in the MHRA Drug Safety Update (Volume 2, Issue 3 October 2008)

October 2012

Hypogonadism
Society for Endocrinology position statement on hypogonadism and ageing

The Society for Endocrinology’s Clinical Committee provides information on the diagnosis and treatment of hypogonadism in ageing men. A patient factsheet to accompany this position statement can be found on the Society’s public website You & Your Hormones

July 2011

Inhaled Steroids
Endocrine effects of inhaled steroids in respiratory disease (pdf) (123kb)

This position statement highlights the suppressive effects of inhaled corticosteroids on the endogenous hypothalamo-pituitary-adrenal axis.

September 2011

Synacthen
Use of synthetic ACTH (Synacthen) in patients with a history of asthma

This statement is issued to coincide with the publication of BNF62 that contains (in section 6.5.1) an amendment to cautions and contraindications in the use of Tetracosactide (Tetracosactrin).

October 2011

Specialist Endocrinology Services
Society for Endocrinology’s information on specialist endocrinology services

This document (originally issued in July 2009 and recently reviewed) explains how the wide range of endocrine conditions are best diagnosed and managed by teams of doctors working in a variety of different clinical settings.

May 2015

British Thyroid Association Statement on the Management of Primary Hypothyroidism (The statement is available on the British Thyroid Foundation website)

This position statement by the British Thyroid Association
(BTA) summarises the key points in recent guidelines and makes
recommendations on the management of primary hypothyroidism
based on the current literature. The statement is endorsed by the
Association of Clinical Biochemistry, (ACB), British Thyroid
Foundation, (BTF), Royal College of Physicians (RCP) and Society for Endocrinology (SFE).

Patient Information

April 2016

Adrenal Insufficiency
Society for Endocrinology information leaflet on adrenal insufficiency

This information leaflet produced by the Society for Endocrinology provides an introduction to the causes and symptoms of adrenal insufficiency and the tests used to diagnose this condition.
Please also see surgical guidelines (2005) developed by the Clinical Advisory Panel of the Addison's Disease Self Help Group (ADSHG).

October 2011

Hyperparathyroidism
Society for Endocrinology information sheet on Primary Hyperparathyroidism

This information leaflet produced by the Society for Endocrinology’s Bone and Mineral Special Interest Group provides information on diagnosis and treatment of this condition.

Guidelines in Development

Late Endocrine Effects of Cancer Therapy

Management of Adults with Congential Adrenal Hyperplasia

Turner’s Syndrome